News
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
3d
Zacks Investment Research on MSNHIMS Stock Dips Pre-Market Despite Q1 Earnings Beat, Gross Margin DownHims & Hers Health, Inc. HIMS delivered an earnings per share (EPS) of 20 cents in first-quarter 2025 compared with the ...
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
Andrew Dudum; Chairman of the Board, Chief Executive Officer; Hims & Hers Health Inc Oluyemi Okupe; Chief Financial Officer; Hims & Hers Health Inc Good afternoon, ladies and gentlemen. Thank you for ...
Shares of Hims & Hers Health (NYSE: HIMS) are soaring as investors react to news about the company's partnership with Novo ...
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
The companies will sell the drug at a reduced price of $499 a month ... example, Hims will charge $100 for the monthly subscription, which also includes a monthly tele-visit with a healthcare provider ...
Novo Nordisk and Hims & Hers Health, Inc. (NYSE: HIMS) today announced a long-term collaboration designed to make proven ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results